Context matters – Daxx and Atrx are not robust tumor suppressors in the murine endocrine pancreas
Open Access
- 26 August 2022
- journal article
- research article
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 15 (8)
Abstract
Genome sequencing has revealed the importance of epigenetic regulators in tumorigenesis. The genes encoding the chromatin remodeling complex DAXX:ATRX are frequently mutated in pancreatic neuroendocrine tumors; however, the underlying mechanisms of how mutations contribute to tumorigenesis are only partially understood, in part because of the lack of relevant preclinical models. Here, we used genetically engineered mouse models combined with environmental stress to evaluate the tumor suppressor functions of Daxx and Atrx in the mouse pancreas. Daxx or Atrx loss, alone or in combination with Men1 loss, did not drive or accelerate pancreatic neuroendocrine tumorigenesis. Moreover, Daxx loss did not cooperate with environmental stresses (ionizing radiation or pancreatitis) or with the loss of other tumor suppressors (Pten or p53) to promote pancreatic neuroendocrine tumorigenesis. However, owing to promiscuity of the Cre promoter used, hepatocellular carcinomas and osteosarcomas were observed in some instances. Overall, our findings suggest that Daxx and Atrx are not robust tumor suppressors in the endocrine pancreas of mice and indicate that the context of a human genome is essential for tumorigenesis. This article has an associated First Person interview with the first author of the paper.Keywords
Funding Information
- National Cancer Institute (R21 CA208463, CA016672)
- Neuroendocrine Tumor Research Foundation
- Canadian Institutes of Health Research
- University of Texas MD Anderson Cancer Center
This publication has 53 references indexed in Scilit:
- Altered Telomeres in Tumors with ATRX and DAXX MutationsScience, 2011
- Inactivation of Brca2 Promotes Trp53-Associated but Inhibits KrasG12D-Dependent Pancreatic Cancer Development in MiceGastroenterology, 2011
- DAXX / ATRX , MEN1 , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine TumorsScience, 2011
- Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeresProceedings of the National Academy of Sciences, 2010
- The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3Genes & Development, 2010
- Gene Amplifications in Well-Differentiated Pancreatic Neuroendocrine Tumors Inactivate the p53 PathwayGenes & Cancer, 2010
- A robust and high-throughput Cre reporting and characterization system for the whole mouse brainNature Neuroscience, 2009
- Chronic Pancreatitis Is Essential for Induction of Pancreatic Ductal Adenocarcinoma by K-Ras Oncogenes in Adult MiceCancer Cell, 2007
- Dual Roles for Glucokinase in Glucose Homeostasis as Determined by Liver and Pancreatic β Cell-specific Gene Knock-outs Using Cre RecombinaseJournal of Biological Chemistry, 1999
- Hypervariable ultra-long telomeres in miceNature, 1990